Skip to Main Content

Paper Details

Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center.
Perioper Med (Lond)
1
2015
Author NameAffiliation
Raquel R BartzDuke University Medical Center
William D WhiteDuke University Medical Center
Tong J GanStony Brook University
  • 1 - 3

Datasets

Release 1.2